Elevation of serum fortilin levels is specific for apoptosis and signifies cell death in vivo.
Elevation of serum fortilin levels is specific for apoptosis and signifies cell death in vivo.
复制标题
DOI:
10.1016/j.bbacli.2014.10.002
复制
发表时间:
2014-12-01
期刊:
影响因子:
--
通讯作者:
Fujise, Ken
中科院分区:
文献类型:
--
作者:
Sinthujaroen, Patuma;Wanachottrakul, Nattaporn;Pinkaew, Decha;Petersen, John R;Phongdara, Amornrat;Sheffield-Moore, Melinda;Fujise, Ken
Billions of cells undergo apoptosis each day in the average normal adult. The ability to readily assess the degree of apoptosis in human diseases is hampered by the lack of sensitive and specific serum biomarkers of apoptosis. Fortilin is a novel prosurvival molecule that protects cells against various noxious stimuli. While fortilin is secreted into the extracellular space under certain conditions, the relationship between the serum concentration of fortilin and the presence and extent of apoptosis in vivo remains unknown. Using a newly developed fortilin ELISA system, we show here that fortilin exists in the normal human and mouse circulation. We further demonstrate that fortilin serum levels are significantly elevated in patients with solid cancer, in response to anti-cancer chemo- or radiation therapy. The elevation of fortilin serum levels is more robust and sensitive than that of such previously-reported serum biomarkers of apoptosis as fragmented cytokeratin-18, cytochrome c, and nucleosomal DNA. In addition, targeted apoptotic liver damage induced by Jo2 anti-Fas (CD95) antibody consistently and significantly increased serum fortilin levels in C57BL/6J mice. Finally, when challenged by anti-human-Fas IgM antibody, Jurkat leukemic T cells apoptosed and released fortilin into the medium before plasma membrane integrity was compromised. Taken together, these data suggest that serum fortilin levels reflect the degree and extent of apoptosis occurring in vivo. Fortilin is a viable serum biomarker of in vivo apoptosis and can be utilized to noninvasively assess the status of in vivo apoptosis in humans. Ultra-sensitive fortilin ELISA has been developed. Fortilin circulates in blood. Fortilin serum levels become highly elevated after apoptosis-inducing therapy. Fortilin is more robust and sensitive than other serum apoptosis markers. Fortilin is actively secreted before plasma membrane becomes disrupted. Fortilin is an excellent serum biomarker of in vivo apoptosis.